Moderna just used a personalized vaccine to treat cancer, and it could signal a major breakthrough in how we treat the disease

Dec 13 2022 by Business Insider

 
Stephane Bancel, CEO of Moderna

Nancy Lane/MediaNews Group/Boston Herald

Moderna's cancer vaccine lowered the risk of death or skin cancer recurrence in a mid-stage study. Analysts say the vaccine's long-term success still needs to be proven.  "Now, we are an oncology company," Moderna CEO Stéphane Bancel told Insider.

The biotech company Moderna just announced a significant advance in its efforts to treat cancer.

Moderna said Tuesday its personalized cancer vaccine program succeeded in a...

Continue Reading Moderna just used a personalized vaccine to treat cancer, and it could signal a major breakthrough in how we treat the disease